We are an innovative biotechnology company engaged in the discovery and development of life-improving drug therapies to treat rare and complex central nervous system, or CNS, disorders, including narcolepsy, idiopathic hypersomnia, or IH, and other rare sleep disorders, as well as neurodevelopmental disorders, such as Attention Deficit Hyperactivity Disorder, or ADHD. Pharmaceutics Ltd. is offering units, or Units, each consisting of one of our common shares and one Warrant to purchase one of our common shares, or, each, a Warrant, in an initial public offering.
$5.00 - $6.00
January 29, 2021
MAXIM GROUP LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for NLS Pharmaceutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277